Skip to main content
TMDX logo
TMDX
(NASDAQ)
TransMedics Group, Inc.
$73.83-- (--)
Loading... - Market loading

TransMedics Group (TMDX) Stock Price & Financial Analysis

TransMedics Group Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$72.79 - $75.78
52-Week High$156.00
52-Week Low$60.11
Open$74.66
Volume822.52K
Average Volume (3M)1.37M
Market Cap2.73B
Shares Outstanding36.19M
P/E Ratio (TTM)15.90
Forward P/E8.70
Price to Sales (P/S)4.30
Price to Book (P/B)5.53
EV/EBITDA22.43
Revenue (TTM)635.89M
Net Income (TTM)171.92M
Free Cash Flow (TTM)151.36M
EPS (TTM)$4.34
Profit Margin27.04%
Operating Margin14.85%
Return on Equity (ROE)34.80%
Debt to Equity1.75
50-Day MA$83.70
200-Day MA$114.89
52-Week Change-38.89%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About TransMedics Group

What is the current stock price for TMDX?

As of the latest trading session, TMDX stock trades at $73.83. The 52-week range is $60.11–$156.00, with a day range of $72.79–$75.78.

What is the P/E ratio for TMDX?

TransMedics Group's trailing P/E ratio is 15.9, meaning investors pay $15.9 for every $1 of annual earnings. The forward P/E is 8.7, reflecting analyst expectations for future earnings. TransMedics Group operates in the Healthcare sector.

Does TMDX pay dividends?

TransMedics Group does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TMDX?

Based on 10 analysts, the consensus for TMDX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TMDX?

TransMedics Group's market capitalization is $2.67B, classifying it as a mid-cap company. TransMedics Group operates in the Healthcare sector within the Medical Devices industry.